{ "docId": "019dd923-5ca1-7489-b639-45501f4b359b", "docSlug": "158df8627a0b9aca", "documentTitle": "Opioid Conflicts Majority Staff Report", "authorId": "McKinsey", "authorName": "U.S. House Committee on Oversight and Reform", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "portrait", "aspectRatio": 0.773, "pageNumber": 50, "pageCount": 53, "prevPage": 49, "nextPage": 51, "slideType": "appendix_disclosure", "function": "summarize", "density": "overcrowded", "nDataPoints": 0, "notes": "This appears to be a page from a congressional or investigative report (page 50).", "elementsJson": [ "paragraph", "quote_block", "footnote" ], "metadataConfidence": 0.9, "imagePath": null, "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/50", "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b", "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json", "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-50", "components": [ { "bbox": null, "kind": "callout", "text": "The Committee has also obtained evidence that McKinsey consultants discussed destroying or hiding documents concerning the firm's work for Purdue.", "attrs": null, "subkind": null, "toolName": "Visual emphasis", "toolSlug": "visual-emphasis", "confidence": null, "componentId": "019dd951-cdec-74db-b49e-60befe10a64e", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.13, "w": 0.78, "x": 0.11, "y": 0.38 }, "kind": "paragraph", "text": "McKinsey had previously sent other opioid policy memos to CMS, even when the firm was seemingly not providing consulting services to CMS. A January 2018 email from a McKinsey consultant to Tom Latkovic stated, “The statistics and recommendations included in our Azar memo were largely culled from the Oct 2017 white paper for CMS, ‘Saving lives now: Perspectives on Accelerating CMS’s Impact in Solving the Opioid Crisis.’”243 According to publicly available federal spending data, McKinsey did not have any ongoing federal contracts at CMS at the time it reportedly submitted the 2017 white paper.244", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "02469bab-297c-4e24-a3c2-8fd159f1fa21", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.78, "x": 0.11, "y": 0.53 }, "kind": "paragraph", "text": "This evidence raises significant questions about how McKinsey’s practice of seeking input from consultants who had served or were serving opioid manufacturers impacted the work product of McKinsey’s government and policy facing health care practice, and about how these recommendations influenced the federal government’s opioid policies.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "38a73520-e499-4873-8906-c35b9e3dc0ed", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.78, "x": 0.11, "y": 0.69 }, "kind": "paragraph", "text": "In May 2017—more than two years before McKinsey announced it would no longer work for opioid manufacturers—Mr. Ghatak and McKinsey partner Laura Moran discussed over text message how to ensure McKinsey documents would not get pulled into Purdue’s ongoing litigation.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "94083bd4-ed89-44fe-9272-9683fa232970", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.03, "w": 0.78, "x": 0.11, "y": 0.64 }, "kind": "paragraph", "text": "The Committee has also obtained evidence that McKinsey consultants discussed destroying or hiding documents concerning the firm’s work for Purdue.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "96e602c3-7999-40c0-8ef9-eb72a7195b1d", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.78, "x": 0.11, "y": 0.11 }, "kind": "paragraph", "text": "Ms. Lane also expressed concerns. The next day, on October 30, 2018, she wrote, “My main concern is that this could be misinterpreted as if we are advocating on behalf of our private sector and other clients to HHS to take specific actions around provider programs, state programs, etc.”242 It is unclear what further action McKinsey took with the OCRA memo.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "a9b2fd91-c012-4584-a00d-ecc7bd576a39", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.13, "w": 0.54, "x": 0.23, "y": 0.2 }, "kind": "quote", "text": "My main concern is that this could be misinterpreted as if we are advocating on behalf of our private sector and other clients to HHS to take specific actions around provider programs, state programs, etc. Julie Lane, McKinsey Healthcare Practice", "attrs": null, "subkind": "pull-quote", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "26553b94-675a-42a9-8654-26fc5dd06c63", "frameworkName": null, "frameworkSlug": null }, { "bbox": null, "kind": "quote", "text": "My main concern is that this could be misinterpreted as if we are advocating on behalf of our private sector and other clients to HHS to take specific actions around provider programs, state programs, etc. — Julie Lane, McKinsey Healthcare Practice", "attrs": null, "subkind": null, "toolName": "Authority citation", "toolSlug": "authority-citation", "confidence": null, "componentId": "019dd951-cdec-74db-b49e-66cf281eaa87", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.78, "x": 0.11, "y": 0.81 }, "kind": "source-note", "text": "242 MCK-HCOR-0170799. 243 MCK-HCOR-0261306, Page 2. 244 USA Spending, McKinsey & Company Contracts with the Centers for Medicare and Medicaid Services Since 2008 (online at www.usaspending.gov/search/?hash=e8ef63dc11ba5bf988e7296b8d0e9036) (accessed Mar. 22, 2022).", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "09e6270f-0e3f-4b22-bc1f-9fd64c90c7f0", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.02, "w": 0.25, "x": 0.11, "y": 0.61 }, "kind": "title", "text": "E. Document Destruction", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "0669be1d-8842-4bd3-b95f-9624ce28d193", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 53, "from": 29, "beatId": "1170eac2-9202-4b41-a53c-edbd934ded10", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "The document concludes with implications of McKinsey's actions and potential next steps for regulatory action.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "loops": [ { "to": 53, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033", "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.", "position": 0, "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }